MGZ (ASX) Pipeline

Originally posted by verce ↑

The Blood Collection Device now has granted patents in Australia, United States, Japan, Canada and Europe with the patent being validated in twenty six European countries.

http://www.medigard.com.au/products-blood-collection-device

The 3ml vacuum retractable syringe has granted patents in South Africa, United States, Australia, China Japan and Canada while the 1ml syringe has patents granted in South Africa, China, Australia, United States and Japan.

http://www.medigard.com.au/products-auto-retractable-syringe

The Blood Flash Needle which will be the next focus for the Company and Sol Millennium has granted patents in Australia, South Africa and Europe.

http://www.medigard.com.au/products-flash-back-needle

__________________________

Later in the pipeline: http://www.medigard.com.au/products-intravenous-valve

The Medigard Intravenous Valve operates both as an essential component of the cannula and as a standalone device.
IV access valves are used extensively where catheters are inserted into the body for an extended period of time. The valves are used as access points in the catheters in preference to a syringe for delivering fluid, administering drugs and taking blood samples. The valve gives needleless access and reduces the risk of needlestick injury.

The Medigard IV Valve is a two-way valve allowing the introduction of liquids and the withdrawal of blood. It provides clear visibility of fluids. A syringe can be inserted with or without a Luer lock.

The Medigard IV Valve design eliminates technology design faults that are common with other IV valve devices. The Medigard device incorporates positive flow that prevents backward flow and the possibility of blood clotting.

Expand

Absolute little cracker this one. From both a medical administrator, nurse, patient and investor perspective.

The last 2 trades were cross-trades (1 at 3.6 the other at 4.0) that popped it from 3.4 cents to 4.0 cents but even so we would love to see it fly...March is looming.

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Absolute little cracker this one. From both a medical...

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Absolute little cracker this one. From both a medical...

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News